POLARGO Trial Shows OS Benefit with Pola-R-GemOx in Transplant-Ineligible R/R DLBCL - report from EHA2025

from Medical Digest & Congress Report · host Medical Congress News

Professor Matthew Matasar explains the highly anticipated results of the Phase III POLARGO trial after the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:polargo-trial-shows-os-benefit-pola-r-gemox-transplant-ineligible-rr-dlbcl

Episode metadata supplied by the publisher feed · Published Jun 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

POLARGO Trial Shows OS Benefit with Pola-R-GemOx in Transplant-Ineligible R/R DLBCL - report from EHA2025

0:00 5:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on June 27, 2025.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!